Clearview Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
Clearview Wealth Advisors's SYNH Position: Q2 2022 in Review
Clearview Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 160 shares — an estimated $1K sold.
Clearview Wealth Advisors first reported a position in SYNH in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.
- Clearview Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
- Clearview Wealth Advisors sold 160 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $1K.
- Clearview Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 3 quarters.
- Clearview Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $1K in Q1 2022.
- 362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.
Based on Clearview Wealth Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.